The FDA approved Biogen Idec's oral drug Tecfidera to treat patients with multiple sclerosis. Tecfidera activates the Nrf2 chemical pathway and is intended to shield nerve cells from damage and inflammation. Biogen is days from commercializing the drug.
Biogen's multiple sclerosis drug Tecfidera gets FDA approval
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan